Transcriptomic Remodelling of Fetal Endothelial Cells During Establishment of Inflammatory Memory.
Animals
Cell Separation
Cells, Cultured
DNA Methylation
Endothelial Progenitor Cells
/ drug effects
Fetus
/ cytology
Gene Expression Regulation
/ drug effects
Gene Ontology
Human Umbilical Vein Endothelial Cells
/ drug effects
Humans
Infant, Newborn
Inflammation
/ embryology
Lipopolysaccharides
/ pharmacology
Mice
NK Cell Lectin-Like Receptor Subfamily D
/ biosynthesis
Nuclear Proteins
/ metabolism
Poly I-C
/ pharmacology
RNA
/ biosynthesis
Transcription Factors
/ metabolism
Transcriptome
HUVEC (human umbilical vein endothelial cells)
endothelial cells
endothelial progenitor cell
inflammation
inflammatory memory
innate immune memory
trained immunity
transcriptome (RNA-seq)
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2021
2021
Historique:
received:
12
08
2021
accepted:
03
11
2021
entrez:
6
12
2021
pubmed:
7
12
2021
medline:
15
3
2022
Statut:
epublish
Résumé
Inflammatory memory involves the molecular and cellular 'reprogramming' of innate immune cells following exogenous stimuli, leading to non-specific protection against subsequent pathogen exposure. This phenomenon has now also been described in non-hematopoietic cells, such as human fetal and adult endothelial cells. In this study we mapped the cell-specific DNA methylation profile and the transcriptomic remodelling during the establishment of inflammatory memory in two distinct fetal endothelial cell types - a progenitor cell (ECFC) and a differentiated cell (HUVEC) population. We show that both cell types have a core transcriptional response to an initial exposure to a viral-like ligand, Poly(I:C), characterised by interferon responsive genes. There was also an ECFC specific response, marked by the transcription factor ELF1, suggesting a non-canonical viral response pathway in progenitor endothelial cells. Next, we show that both ECFCs and HUVECs establish memory in response to an initial viral exposure, resulting in an altered subsequent response to lipopolysaccharide. While the capacity to train or tolerize the induction of specific sets of genes was similar between the two cell types, the progenitor ECFCs show a higher capacity to establish memory. Among tolerized cellular pathways are those involved in endothelial barrier establishment and leukocyte migration, both important for regulating systemic immune-endothelial cell interactions. These findings suggest that the capacity for inflammatory memory may be a common trait across different endothelial cell types but also indicate that the specific downstream targets may vary by developmental stage.
Identifiants
pubmed: 34867995
doi: 10.3389/fimmu.2021.757393
pmc: PMC8640490
doi:
Substances chimiques
ELF1 protein, human
0
KLRD1 protein, human
0
Lipopolysaccharides
0
NK Cell Lectin-Like Receptor Subfamily D
0
Nuclear Proteins
0
Transcription Factors
0
RNA
63231-63-0
Poly I-C
O84C90HH2L
Types de publication
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
757393Subventions
Organisme : Austrian Science Fund FWF
ID : DOC 31
Pays : Austria
Informations de copyright
Copyright © 2021 Weiss, Vlahos, Kim, Wijegunasekara, Shanmuganathan, Aitken, Joo, Imran, Shepherd, Craig, Green, Hiden, Novakovic and Saffery.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Mol Med (Berl). 2020 Jun;98(6):819-831
pubmed: 32350546
Diabetologia. 2018 Nov;61(11):2398-2411
pubmed: 30091044
Blood. 2004 Nov 1;104(9):2752-60
pubmed: 15226175
Nat Rev Immunol. 2020 Jun;20(6):375-388
pubmed: 32132681
Transplantation. 1984 Sep;38(3):293-8
pubmed: 6591602
Mol Cell. 2010 May 28;38(4):576-89
pubmed: 20513432
Cell Mol Life Sci. 1998 Sep;54(9):965-78
pubmed: 9791539
Blood. 2004 Apr 1;103(7):2577-84
pubmed: 14630797
Science. 2016 Apr 22;352(6284):aaf1098
pubmed: 27102489
J Hematol Oncol. 2014 Oct 31;7:80
pubmed: 25387998
Nature. 2007 Jun 21;447(7147):972-8
pubmed: 17538624
BMC Genomics. 2013 Jul 15;14:475
pubmed: 23855827
J Immunol. 2007 Jan 15;178(2):1122-35
pubmed: 17202376
Bioinformatics. 2014 May 15;30(10):1363-9
pubmed: 24478339
Clin Sci (Lond). 2016 Mar;130(6):451-61
pubmed: 26669797
Blood. 1997 May 1;89(9):3228-35
pubmed: 9129027
Genome Biol. 2011;12(2):R13
pubmed: 21310039
Atherosclerosis. 2015 Apr;239(2):496-502
pubmed: 25721701
Int J Epidemiol. 2012 Feb;41(1):55-61
pubmed: 22422448
Curr Protoc Bioinformatics. 2010 Dec;Chapter 11:Unit 11.7
pubmed: 21154709
Exp Cell Res. 2021 Mar 15;400(2):112485
pubmed: 33515594
Cell Host Microbe. 2018 Jan 10;23(1):89-100.e5
pubmed: 29324233
Genome Biol. 2014;15(12):550
pubmed: 25516281
Genes Dev. 2019 Sep 1;33(17-18):1159-1174
pubmed: 31371436
Transl Res. 2017 Feb;180:53-67.e4
pubmed: 27567430
Cell. 2018 Jan 11;172(1-2):135-146.e9
pubmed: 29328908
Cell. 2016 Nov 17;167(5):1354-1368.e14
pubmed: 27863248
Arterioscler Thromb Vasc Biol. 2008 Sep;28(9):1584-95
pubmed: 18669889
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Nature. 2020 Jul;583(7815):296-302
pubmed: 32612232
Nat Immunol. 2021 Jan;22(1):2-6
pubmed: 33293712
Lancet. 2001 Jun 2;357(9270):1777-89
pubmed: 11403834
Proc Natl Acad Sci U S A. 2013 Oct 15;110(42):16981-6
pubmed: 24082146
Cell Metab. 2016 Dec 13;24(6):807-819
pubmed: 27866838
Nature. 2017 Oct 26;550(7677):475-480
pubmed: 29045388
Genome Biol. 2016 Oct 7;17(1):208
pubmed: 27717381
Blood Transfus. 2014 Jan;12 Suppl 1:s367-74
pubmed: 23867184
Cell Metab. 2019 Jul 2;30(1):1-2
pubmed: 31204280
J Mol Cell Cardiol. 2020 Sep;146:121-132
pubmed: 32726647
Placenta. 2017 Oct;58:122-132
pubmed: 28962690
Arterioscler Thromb Vasc Biol. 2021 Mar;41(3):1032-1046
pubmed: 33380171
J Am Soc Nephrol. 2004 Aug;15(8):1983-92
pubmed: 15284284
Trends Immunol. 2009 Oct;30(10):475-87
pubmed: 19781994
J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S33-40
pubmed: 20061006
Nat Commun. 2016 Jan 08;7:10160
pubmed: 26744078
PLoS Pathog. 2019 Nov 4;15(11):e1007634
pubmed: 31682641
Bioinformatics. 2016 Jan 15;32(2):286-8
pubmed: 26424855
Nat Biotechnol. 2010 May;28(5):495-501
pubmed: 20436461
Front Immunol. 2017 Dec 22;8:1907
pubmed: 29312357
Cell. 2009 Dec 24;139(7):1243-54
pubmed: 20064371
J Immunol. 2007 Oct 1;179(7):4397-404
pubmed: 17878335
PLoS One. 2011;6(8):e23547
pubmed: 21853150
Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17537-42
pubmed: 22988082
J Biol Chem. 2014 Jan 24;289(4):2457-68
pubmed: 24307174
Histochem Cell Biol. 2019 Nov;152(5):377-390
pubmed: 31541300
Front Cell Dev Biol. 2019 Mar 19;7:32
pubmed: 30949477
Immunity. 2015 Mar 17;42(3):484-98
pubmed: 25746953
Lancet Diabetes Endocrinol. 2019 Oct;7(10):796-806
pubmed: 31128973
Clin Exp Immunol. 1999 Nov;118(2):298-303
pubmed: 10540194
J Immunol. 2007 May 15;178(10):6017-22
pubmed: 17475823
Genome Biol. 2012 Jun 15;13(6):R44
pubmed: 22703947
Inflammation. 2011 Dec;34(6):509-18
pubmed: 20878353
Cell Rep. 2020 Apr 21;31(3):107548
pubmed: 32320649
PLoS One. 2014 Mar 20;9(3):e91334
pubmed: 24651450
Clin Transl Immunology. 2021 Feb 18;10(2):e1253
pubmed: 33708384
Am J Physiol Heart Circ Physiol. 2014 Feb;306(3):H317-25
pubmed: 24285111